Kenya joins global trial of Oxford's COVID-19 vaccine candidate
Kenya Medical Research Institute has said that Kenya has joined the global clinical trial of Oxford University's vaccine candidate against coronavirus. The candidate, which was jointly developed with AstraZeneca, is already being evaluated in Britain, South Africa and Brazil. The trial in Kenya will initially involve 40 frontline workers while another 360 volunteers will join at a later stage.